Education
About Us
Working with TipRanks
Follow Us
Medtronic (MDT)
NYSE:MDT
MDT Stock Chart & Stats
Day’s Range― - ―
52-Week Range$75.96 - $96.25
Previous CloseN/A
Volume4.67M
Average Volume (3M)7.16M
Market Cap
$105.58B
Enterprise Value$132.43B
Total Cash (Recent Filing)$7.92B
Total Debt (Recent Filing)$26.61B
Price to Earnings (P/E)25.4
Beta0.51
Next Earnings
May 21, 2025EPS Estimate
1.58Last Dividend Ex-Date
Mar 28, 2025Dividend Yield3.35%
Share Statistics
EPS (TTM)1.39
Shares Outstanding1,282,543,500
10 Day Avg. Volume5,898,249
30 Day Avg. Volume7,163,574
Financial Highlights & Ratios
PEG Ratio41.21
Price to Book (P/B)2.17
Price to Sales (P/S)0.00
P/FCF Ratio19.58
Enterprise Value/Market Cap1.25
Enterprise Value/Revenue1.01
Enterprise Value/Gross Profit6.34
Enterprise Value/Ebitda3.62
Forecast
1Y Price Target
$96.00Price Target Upside15.00% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering19
---
Bulls Say, Bears Say
Bulls Say
Clinical DataMDT's SMART trial 2-year follow-up results demonstrate that the Evolut TAVR platform continues to demonstrate superior bioprosthetic valve dysfunction (BVD) rates compared to Edwards' Sapien system in small annuli patients.
EarningsA good quarter with upside on revenue that shows MDT is executing better than value medtech with a better pipeline should help MDT defend its multiple.
Product InnovationMDT announced FDA approval of the Simplera Sync sensor for the 780G insulin pump, which should make MDT more competitive.
Bears Say
Economic EnvironmentMedtronic has been hit by a train of headwinds such as inflation, higher labor costs and higher material costs.
Financial PerformanceNet profit margins have fallen from 16.6% to 11.4%.
Market CompetitionMedtronic is at risk of losing 50% of its insulin pump market to GLP-1 drugs.
---
Ownership Overview
0.07% Insiders
24.33% Mutual Funds
0.64% Other Institutional Investors
53.89% Public Companies and
Individual Investors
MDT FAQ
What was Medtronic’s price range in the past 12 months?
Medtronic lowest stock price was $75.96 and its highest was $96.25 in the past 12 months.
What is Medtronic’s market cap?
Medtronic’s market cap is $105.58B.
When is Medtronic’s upcoming earnings report date?
Medtronic’s upcoming earnings report date is May 21, 2025 which is in 8 days.
How were Medtronic’s earnings last quarter?
Medtronic released its earnings results on Feb 18, 2025. The company reported $1.39 earnings per share for the quarter, beating the consensus estimate of $1.36 by $0.03.
Is Medtronic overvalued?
According to Wall Street analysts Medtronic’s price is currently Undervalued.
Does Medtronic pay dividends?
Medtronic pays a Quarterly dividend of $0.699 which represents an annual dividend yield of 3.35%. See more information on Medtronic dividends here
What is Medtronic’s EPS estimate?
Medtronic’s EPS estimate is 1.58.
How many shares outstanding does Medtronic have?
Medtronic has 1,282,543,500 shares outstanding.
What happened to Medtronic’s price movement after its last earnings report?
Medtronic reported an EPS of $1.39 in its last earnings report, beating expectations of $1.36. Following the earnings report the stock price went down -7.265%.
Which hedge fund is a major shareholder of Medtronic?
Currently, no hedge funds are holding shares in MDT
---
Medtronic Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$96.00 (15.00% Upside)
$96.00 (15.00% Upside)
Blogger Sentiment
Bullish
MDT Sentiment 93%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 356.7K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.1M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▼ 0.9%
Last 30 Days >0.1%
Last 30 Days >0.1%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
4.08%
12-Months-Change
Fundamentals
Return on Equity
8.42%
Trailing 12-Months
Asset Growth
-0.95%
Trailing 12-Months
Company Description
Medtronic
Medtronic plc is a global leader in medical technology, services, and solutions. Headquartered in Dublin, Ireland, and operationally headquartered in Minneapolis, Minnesota, Medtronic operates in four major segments: Cardiac and Vascular Group, Minimally Invasive Therapies Group, Restorative Therapies Group, and Diabetes Group. The company develops, manufactures, and markets a wide range of medical devices and technologies to treat various chronic diseases and conditions, including cardiovascular diseases, diabetes, and neurological disorders. Medtronic's mission is to alleviate pain, restore health, and extend life, serving healthcare systems, physicians, and patients in over 150 countries worldwide.
---
MDT Company Deck
---
MDT Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call was largely positive, highlighting strong revenue growth, advancements in key segments, and successful international expansion. However, some challenges in the surgical portfolio and distributor dynamics were noted.Read More>---
MDT Net sales Breakdown
36.56% Cardiovascular
29.06% Neuroscience
26.01% Medical Surgical
7.69% Diabetes
0.68% Other operating segment
---
MDT Stock 12 Month Forecast
Average Price Target
$96.00
▲(15.00% Upside)
Technical Analysis
---